Eduard Jirkovský

1.6k total citations · 1 hit paper
30 papers, 1.2k citations indexed

About

Eduard Jirkovský is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Eduard Jirkovský has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pathology and Forensic Medicine and 6 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Eduard Jirkovský's work include Chemotherapy-induced cardiotoxicity and mitigation (15 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Cardiac Ischemia and Reperfusion (5 papers). Eduard Jirkovský is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (15 papers), Effects and risks of endocrine disrupting chemicals (5 papers) and Cardiac Ischemia and Reperfusion (5 papers). Eduard Jirkovský collaborates with scholars based in Czechia, Slovenia and United States. Eduard Jirkovský's co-authors include Martin Štěrba, Tomáš Šimůnek, Vladimír Geršl, Olga Popelová, Anna Vávrová, Petra Kovařı́ková, Přemysl Mladěnka, Jana Pourová, Lucie Nováková and Lenka Kujovská Krčmová and has published in prestigious journals such as PLoS ONE, Chemosphere and Journal of Medicinal Chemistry.

In The Last Decade

Eduard Jirkovský

26 papers receiving 1.2k citations

Hit Papers

Vitamin C—Sources, Physiological Role, Kinetics, Deficien... 2021 2026 2022 2024 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vitamin C—Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination
    2021 310 citations Eduard Jirkovský, Jana Pourová et al. Nutrients profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduard Jirkovský Czechia 15 478 308 203 184 172 30 1.2k
Michela Pecoraro Italy 16 280 0.6× 481 1.6× 146 0.7× 103 0.6× 119 0.7× 33 1.3k
Wesam M. El‐Bakly Egypt 15 267 0.6× 329 1.1× 211 1.0× 46 0.3× 156 0.9× 29 1.2k
Dinender Kumar Canada 16 829 1.7× 722 2.3× 251 1.2× 86 0.5× 309 1.8× 22 1.7k
Iyyapu Krishna Mohan India 19 163 0.3× 247 0.8× 74 0.4× 186 1.0× 175 1.0× 38 1.2k
Monika Barteková Slovakia 22 465 1.0× 688 2.2× 96 0.5× 87 0.5× 284 1.7× 57 1.6k
István Lekli Hungary 27 281 0.6× 897 2.9× 116 0.6× 144 0.8× 293 1.7× 74 2.1k
Róbert Halmosi Hungary 19 334 0.7× 421 1.4× 246 1.2× 45 0.2× 225 1.3× 42 1.3k
Qiao Yang China 19 220 0.5× 484 1.6× 136 0.7× 60 0.3× 93 0.5× 48 1.1k
Shih‐Hurng Loh Taiwan 20 413 0.9× 512 1.7× 83 0.4× 61 0.3× 118 0.7× 66 1.3k
Wawaimuli Arozal Indonesia 21 277 0.6× 342 1.1× 99 0.5× 43 0.2× 119 0.7× 93 1.2k

Countries citing papers authored by Eduard Jirkovský

Since Specialization
Citations

This map shows the geographic impact of Eduard Jirkovský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduard Jirkovský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduard Jirkovský more than expected).

Fields of papers citing papers by Eduard Jirkovský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduard Jirkovský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduard Jirkovský. The network helps show where Eduard Jirkovský may publish in the future.

Co-authorship network of co-authors of Eduard Jirkovský

This figure shows the co-authorship network connecting the top 25 collaborators of Eduard Jirkovský. A scholar is included among the top collaborators of Eduard Jirkovský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduard Jirkovský. Eduard Jirkovský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mladěnka, Přemysl, Patrícia Dias, Jana Pourová, et al.. (2025). The first subacute study with oral administration of bisphenol AP in male rats: Cardiovascular data and metabolite detection. Ecotoxicology and Environmental Safety. 304. 119143–119143.
2.
Hrubša, Marcel, Eduard Jirkovský, Alejandro Carazo, et al.. (2025). A novel bisphenol A alternative, DD-70, may negatively affect haemostasis through cyclooxygenase 1 inhibition. Environment International. 203. 109738–109738.
3.
Dias, Patrícia, Jana Pourová, Marie Vopršalová, et al.. (2024). The quercetin metabolite 4-methylcatechol causes vasodilation via voltage-gated potassium (KV) channels. Food & Function. 15(22). 11047–11059.
4.
Jirkovský, Eduard, et al.. (2024). Small phenolic compounds as potential endocrine disruptors interacting with estrogen receptor alpha. Frontiers in Endocrinology. 15. 1440654–1440654. 1 indexed citations
5.
Pourová, Jana, et al.. (2024). 3-methoxycatechol causes vasodilation likely via KV channels: ex vivo, in silico docking and in vivo study. Vascular Pharmacology. 156. 107418–107418. 1 indexed citations
6.
Dias, Patrícia, Jana Pourová, Eduard Jirkovský, et al.. (2023). P09-01: The effects of bisphenols on the cardiovascular system ex vivo and in vitro. Toxicology Letters. 384. S132–S133. 1 indexed citations
7.
Carazo, Alejandro, Eduard Jirkovský, Jana Pourová, et al.. (2022). The effects of bisphenols on the cardiovascular system ex vivo and in vivo. Chemosphere. 313. 137565–137565. 12 indexed citations
8.
Hrubša, Marcel, Eduard Jirkovský, David Biedermann, et al.. (2021). Silymarin Dehydroflavonolignans Chelate Zinc and Partially Inhibit Alcohol Dehydrogenase. Nutrients. 13(12). 4238–4238. 10 indexed citations
9.
Karabanovich, Galina, Eduard Jirkovský, Y Mazurová, et al.. (2020). Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIβ Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity. Journal of Pharmacology and Experimental Therapeutics. 373(3). 402–415. 14 indexed citations
10.
Jirkovský, Eduard, Markéta Hlaváčková, Hana Jansová, et al.. (2019). In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline. Clinical Science. 133(16). 1827–1844. 12 indexed citations
11.
Jirkovský, Eduard, Jan Bureš, Jaroslav Chládek, et al.. (2017). Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart. Journal of Pharmacology and Experimental Therapeutics. 364(3). 433–446. 19 indexed citations
12.
Jansová, Hana, Eduard Jirkovský, Jan Bureš, et al.. (2016). Are cardioprotective effects of NO-releasing drug molsidomine translatable to chronic anthracycline cardiotoxicity settings?. Toxicology. 372. 52–63. 2 indexed citations
13.
Adamcová, Michaela, Eduard Jirkovský, Y Mazurová, et al.. (2015). Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value. International Journal of Cardiology. 201. 358–367. 6 indexed citations
14.
Jirkovský, Eduard, Hana Jansová, Y Mazurová, et al.. (2015). Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane. Journal of Molecular and Cellular Cardiology. 91. 92–103. 18 indexed citations
15.
Jirkovský, Eduard, Y Mazurová, Juraj Lenčo, et al.. (2014). Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up. PLoS ONE. 9(5). e96055–e96055. 33 indexed citations
16.
Jirkovský, Eduard, M Hroch, Michaela Adamcová, et al.. (2013). Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits. Toxicology. 311(3). 191–204. 30 indexed citations
17.
Štěrba, Martin, Olga Popelová, Anna Vávrová, et al.. (2012). Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection. Antioxidants and Redox Signaling. 18(8). 899–929. 276 indexed citations
18.
Jirkovský, Eduard, Olga Popelová, Anna Vávrová, et al.. (2012). Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways. Journal of Pharmacology and Experimental Therapeutics. 343(2). 468–478. 48 indexed citations
19.
Štěrba, Martin, Olga Popelová, Juraj Lenčo, et al.. (2011). Proteomic insights into chronic anthracycline cardiotoxicity. Journal of Molecular and Cellular Cardiology. 50(5). 849–862. 57 indexed citations
20.
Vávrová, Anna, Olga Popelová, Martin Štěrba, et al.. (2010). In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity. Archives of Toxicology. 85(5). 525–535. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Pecoraro Breakdown of academic impact, for papers by Wesam M. El‐Bakly Breakdown of academic impact, for papers by Dinender Kumar Breakdown of academic impact, for papers by Iyyapu Krishna Mohan Breakdown of academic impact, for papers by Monika Barteková Breakdown of academic impact, for papers by István Lekli Breakdown of academic impact, for papers by Róbert Halmosi Breakdown of academic impact, for papers by Qiao Yang Breakdown of academic impact, for papers by Shih‐Hurng Loh Breakdown of academic impact, for papers by Wawaimuli Arozal
Rankless by CCL
2026